Efficacy of medical treatment in Cushing's disease: a systematic review. - Test2 - elhamkhani - TriplyDB

Efficacy of medical treatment in Cushing's disease: a systematic review.

Efficacy of medical treatment in Cushing's disease: a systematic review.

http://www.wikidata.org/entity/Q38151882

about

Advancing Treatment of Pituitary Adenomas through Targeted Molecular Therapies: The Acromegaly and Cushing Disease Paradigms Clinical use of pasireotide for Cushing's disease in adults The Treatment of Cushing's Disease.Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis The Role of Isotretinoin Therapy for Cushing's Disease: Results of a Prospective Study.Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease.Recent advances in the medical treatment of Cushing's disease.Current status on histological classification in Cushing's disease.Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.Medical combination therapies in Cushing's disease.Emerging drugs for Cushing's disease.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma.Dimethoxy-etomidate: A Non-hypnotic Etomidate Analog that Potently Inhibits Steroidogenesis.Decreased expression of SFRP2 promotes development of the pituitary corticotroph adenoma by upregulating Wnt signaling.Downregulation of Insulin-like growth factor binding protein 6 is associated with ACTH-secreting pituitary adenoma growth.

P2860

Q26741707-1518F868-99FC-46D1-8BA1-D84744FD76D8 Q26858933-26071F8B-CDC0-45C7-BC58-E8F183753A33 Q27010590-42FF7395-F47B-4BF9-BE9F-6799596BEA78 Q28547156-3F6365F6-E6F8-4F24-863A-559D20E011C4 Q36681083-69C0A4F9-FD55-474B-AA53-98B0BC41E677 Q36704499-16B65531-964F-45C2-B7DC-833420CEA016 Q37621524-C3217C99-4C92-4089-B006-ECF13F63D612 Q38287030-A78A6E33-C051-43A7-B93A-84DF55D05173 Q38307934-55A27236-E342-4ADB-9933-F250BDA7493E Q38342520-E324C94E-3043-435B-BF9D-6557BC75362B Q38505947-CA64F16E-2A7F-42E9-BC87-3E67E73AAEEE Q38683309-8B49D1A4-31C0-41D2-B19B-D3851C6BC37A Q39074559-2B80DA3C-498B-43E7-A336-50FD3AE924C4 Q47224599-21FD79B6-0B04-418E-BD37-F21806938A34 Q53796745-6D1D7A65-D268-44F4-AC00-B22349BACE42 Q54229628-33C0A76A-9B4F-4988-B25B-46F0184D0EF8

P2860

Efficacy of medical treatment in Cushing's disease: a systematic review.

http://www.wikidata.org/entity/Q38151882

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Efficacy of medical treatment in Cushing's disease: a systematic review.

@en

type

label

Efficacy of medical treatment in Cushing's disease: a systematic review.

@en

prefLabel

Efficacy of medical treatment in Cushing's disease: a systematic review.

@en

P1433

Q38151882-6C7AFF94-9D5D-4F70-8CEC-6D8FEEC14ABD

P1476

Q38151882-2781EE13-AA02-4D17-99F0-122BD10ABBF7

P2093

Q38151882-DA9E2E03-EE6D-4B83-874C-5503C6B34580

P2860

Q38151882-158B8A41-3E2D-4183-A763-1D3AA4813DA8

Q38151882-178E87AC-401B-4812-A2D9-A9A12C55E9CF

Q38151882-222D6FAB-7342-48AF-809B-25C3BA1BCBBC

Q38151882-24691517-99C4-49EB-8173-52726D58195C

Q38151882-289B3FF2-C536-4435-B329-2CE01E54F348

Q38151882-2AC1DAD8-CFC5-4294-A4F8-B495624F5230

Q38151882-329F459D-0804-47AB-AB8B-FBA455F641E6

Q38151882-40F01498-1320-40B9-AD33-F573D8B9B040

Q38151882-429D2C40-BE6F-4910-9335-0194A279D2C9

Q38151882-4712BFFA-8A06-407F-AB0C-A9CBB3DF9101

P304

Q38151882-CAF16FEB-98EB-45CF-B8AB-6FFA4D440301

P31

Q38151882-9404CD0B-447F-45BF-B574-B9C4F5B0207F

P356

Q38151882-7A43B355-4903-4637-83BD-AAD5BA75BDDC

P433

Q38151882-26FE8A91-CDFF-4372-8E6C-2587759ABF14

P478

Q38151882-D558377F-E5DC-423F-84FA-7C7B256D9F50

P50

Q38151882-A5F312D6-0492-4423-8F8C-DABB6212C3F6

P577

Q38151882-CD1B777C-1A13-43F8-B87A-435332D62100

P5875

Q38151882-B2D07EBC-B36E-4C56-8588-FF4C63BA5A93

P698

Q38151882-0740FEA6-98E4-4930-AE16-DFBBC9C50246

P356

P1433

Clinical Endocrinology

P1476

Efficacy of medical treatment in Cushing's disease: a systematic review

@en

P2093

Mônica R Gadelha

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

What is "quality of evidence" and why is it important to clinicians?

Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.

Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.

Mortality in Cushing's syndrome: a systematic review and meta-analysis.

Hypopituitarism: clinical features, diagnosis, and management.

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Novel insights in dopamine receptor physiology.

Mifepristone (RU 486) in Cushing's syndrome.

Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acrome

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEN.12345

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Leonardo Vieira Neto

P577

2013-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257751227

http://www.w3.org/2001/XMLSchema#string

P698

24118077

http://www.w3.org/2001/XMLSchema#string